Establishment Labs Holdings (ESTA) Capital Expenditures (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.37% |
| Dec 31, 2025 | 354.48% |
| Sep 30, 2025 | -246.37% |
| Jun 30, 2025 | 115.67% |
| Mar 31, 2025 | -84.72% |
| Dec 31, 2024 | 602.86% |
| Sep 30, 2024 | -214.35% |
| Jun 30, 2024 | -34.53% |
| Mar 31, 2024 | -56.47% |
| Dec 31, 2023 | -65.65% |
| Sep 30, 2023 | 3,630.24% |
| Jun 30, 2023 | -106.53% |
| Mar 31, 2023 | 246.13% |
| Dec 31, 2022 | 106.48% |
| Sep 30, 2022 | -204.74% |
| Jun 30, 2022 | 1,926.19% |
| Mar 31, 2022 | 320.00% |
| Dec 31, 2021 | -92.88% |
| Sep 30, 2021 | 1,965.03% |
| Jun 30, 2021 | -200.00% |
| Mar 31, 2021 | 576.67% |
| Dec 31, 2020 | -101.66% |
| Sep 30, 2020 | 2,760.29% |
| Jun 30, 2020 | -117.22% |
| Mar 31, 2020 | 107.66% |
| Dec 31, 2019 | -796.09% |
| Sep 30, 2019 | -82.34% |
| Jun 30, 2019 | 512.70% |
| Mar 31, 2019 | 851.39% |
| Dec 31, 2018 | 128.46% |
| Sep 30, 2018 | -250.60% |
| Jun 30, 2018 | -76.99% |
| Mar 31, 2018 | 249.90% |
| Dec 31, 2017 | -230.91% |